Clinical trials
Terminated Non-Muscle Invasive Bladder Neoplasms trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2011 | 3 |
| 2012 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 1 |
| 2021 | 3 |
| 2023 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 15 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Spectrum Pharmaceuticals, Inc | 3 |
| Endo USA Inc., a Keenova Therapeutics Company | 2 |
| Altor BioScience | 1 |
| Anchiano Therapeutics Israel Ltd. | 1 |
| Astellas Pharma Global Development, Inc. | 1 |
| Baylor College of Medicine | 1 |
| Bristol-Myers Squibb | 1 |
| Ferring Pharmaceuticals | 1 |
| Istari Oncology, Inc. | 1 |
| Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-Muscle Invasive Bladder Neoplasms | 15 |
| Urinary Bladder Neoplasms | 13 |
| Carcinoma, Transitional Cell | 4 |
| Carcinoma in Situ | 3 |
| Neoplasms | 2 |
| Carcinoma, Non-Small-Cell Lung | 1 |
| Colorectal Neoplasms | 1 |
| Melanoma | 1 |
| Neoplasm Metastasis | 1 |
| Neoplasms by Site | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.